Prognostic usefulness of an increase of N-terminal proatrial natriuretic peptide during exercise in patients with chronic heart failure.
Larsen
Alf Inge
AI
Cardiology Division, Central Hospital in Rogaland, Stavanger, Norway. al-i-lar@online.no
Hall
Christian
C
Aukrust
Pål
P
Aarsland
Torbjørn
T
Faris
Peter
P
Dickstein
Kenneth
K
D000368:Aged; D009320:Atrial Natriuretic Factor / Q000097:blood*; D015444:Exercise / Q000502:physiology*; D005080:Exercise Test; D006333:Heart Failure / Q000097:blood*; D006801:Humans; D016209:Interleukin-8 / Q000032:analysis; D019344:Lactic Acid / Q000097:blood; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011498:Protein Precursors / Q000097:blood*; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis*
D016209:Interleukin-8; C099254:N-terminal proatrial natriuretic peptide; D011498:Protein Precursors; D014409:Tumor Necrosis Factor-alpha; D019344:Lactic Acid; D009320:Atrial Natriuretic Factor